Barclays Starts Emerson (EMR) at Equalweight, $55 Price Target
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $156.02 +0.84%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays initiates coverage on shares of Emerson (NYSE: EMR) with an Equalweight rating and $55 price target.
For more ratings news on Emerson click here and for the rating history of Emerson click here.
Shares of Emerson closed at $46.38 yesterday.
For more ratings news on Emerson click here and for the rating history of Emerson click here.
Shares of Emerson closed at $46.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- DA Davidson Starts Everus (ECG) at Buy
- BofA Securities Starts Mobility Global (MBGL) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
